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This paper reviews experiments done in the author's laboratory which led to thediscoveryofan
Epstein-Barr virus (EBV) gene, BZLF1, whoseproduct, ZEBRA, switchesthevirusfrom latency
to the replicative phase of its life cycle. Recent experiments are summarized which explore the
effects of EBV genome rearrangements and cell background on the expression of ZEBRA, and
which investigate the viral targets ofZEBRA action.
BIOLOGIC PROPERTIES OF EBV
There are two central biologic phenomena which virologists interested in the path-
ogenesis of Epstein-Barr virus (EBV) hope to explore at a molecular level. The first is
the immortalization of B lymphocytes. The virus changes a resting B cell into a
continuously proliferating cell in vitro and similar events accompany in vivo infection.
The central question is: Which viral and cellular genes participate in this process?
Among thecrucial viral products are a groupoften genes which areexpressed in latent
infection. These include six nuclear products (EBNAs), two small RNAs (EBERs), a
latent membrane protein (LMP) and an mRNA (TP) which represents a second
putative membrane protein [1-6].
Oncethecell is immortalized, it usually maintains the EBV genome in a latent state,
expressing these ten products. Thevirus's life cycle can, however, be switched between
latency and replication by a variety ofinducing stimuli. Following induction, as many
as 100 viral genes are expressed. Inducing agents include the phorbol ester TPA,
butyrate, anti-immunoglobulin, and serum factors. A potent inducing stimulus is virus
from the HR-I strain ofEBV (Fig. 1).
The HR-I strain is an unusual mutant EBV. It has two remarkable properties. The
first is that thevirus is unable to immortalize B lymphocytes [7]. This defect correlates
with a large genomic deletion which affects the structural gene for EBNA 2 as well as
two downstream exons of a protein we call EBNA 4 and others term leader protein
(LP) [8-10]. Recent studies by Rooney and colleagues indicate that this deletion
also impairs expression of EBNA 1 and EBERs after HR-I virus infects primary
lymphocytes [11]; that is, the deletion in HR-I virus affects expression ofother genes
which are not deleted but apparently dependent for their synthesis on the deleted gene
product(s). The second remarkable property of HR-I virus is that when it is added to
cells with a latent EBV, HR-I activates the expression of early replicative proteins
[12].
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We wished to identify the viral genomic alterations which could account for these
remarkable biologic properties. A potentially confusing finding was that HR-I viral
DNA contained submolar and hypermolar restriction fragments which were not
present in preparations of viral DNA from other strains. We called this het (for
heterogeneous) DNA. The approach we took was to examine clones of the HR-I cell
line for the presence ofhet DNA. We found that nearly all ofthe HR-1 cell clones had
lost the het DNA which was retained in only one of 200 HR-1 subclones which were
examined [13,14]. Of more interest, there was a marked difference in the biologic
characteristics of HR-I cell clones which lacked het DNA and the rare one which
retained it. Retention of het DNA was associated with the spontaneous expression of
viral replicative products. In the majority of clones which lacked het DNA, the virus
remained latent.
An additional experiment demonstrated that HR-I virus stockscontaining het DNA
were able to transactivate immortalizing EBV when added to a cell line with latent
virus [15]. Virus could be recovered from some het (-) cell clones by treatment with
chemical inducing agents such as phorbol ester. When added in multiplicities
equivalent to that of het+ virus, however, virus without het DNA was found to be
incapable of activating replication of the endogenous virus. The virus which was
recovered from latently infected cells following addition of HR-1 het+ virus was
shown to be the endogenous virus latent in the cells and not a recombinant, by use of
restriction fragment length polymorphisms which distinguished the endogenous from
the superinfecting virus.
CHARACTERISTICS OF het DNA
Het DNA represents a defective EBV genome. It is maintained in the HR-I culture
by spreading extracellularly from cell to cell rather than by partitioning vertically as
does the standard EBV plasmid [16]. Het DNA is extensively deleted and rearranged.
There have been several intramolecular recombinations which join non-contiguous
portions ofthe genome, and in several instances the intramolecular recombinations are
accompanied by inversion ofsequences.
A crucial portion of het DNA is arranged as a 16 Kbp palindrome [17]. This
palindrome is perfect except for the central 341 bp, which is derived from the viral
large internal repeat; however, this central region is alsocapableofforming a stem and
loop structure [18]. The net result of these rearrangements in het DNA is to truncate
some open reading frames and to bring other open reading frames next to new
upstream and downstream sequences.
206THE SWITCH BETWEEN EBV LATENCY AND REPLICATION
Identification and Characterization ofthe Active Component ofhet DNA
The experiment which led to identification of the region of het DNA which disrupts
latency consisted first of molecular cloning all of the het DNA as individual BamHI
fragments into the pSV2neo vector. These recombinant plasmids were introduced
individually into monolayer cells (D98/HR-1) which contained a latent EBV genome.
From these experiments one 2.7 Kbp fragment, designated WZhet, was found by
Countryman to activate expression of many viral replicative polypeptides [19]. The
effect of introducing WZhet was similar to treating the cells with an inducing
chemical, such as TPA.
The DNA sequence of WZhet was determined by Jenson [20]. It represents a
recombination and inversion of two regions of EBV DNA which are usually more than
50 Kbp apart on the standard EBV genome. Only one intact open reading frame is
present: BZLF1. Three other open reading frames, BWRF1, BZLF2, and BRLF1 are
truncated in the active WZhet fragment. Therefore, while it was likely that the BZLF1
open reading frame encoded the responsible product, the contributions of the other
partial open reading frames needed to be evaluated.
Countryman found that the product of the BZLF1 gene present in WZhet had a
slower electrophoretic mobility than the product from the standard BamHI Z
fragment. This result suggested that perhaps a product active in disrupting latency was
formed by exon fusion or shuffle. When deletion mutants were constructed which
removed all of the sequences from BamHI W, however, the protein was unaffected
[21 ]. Thus the rearrangement did not contribute to the structure of the protein. Instead
anomalous electrophoretic mobility was due to one or more of five point mutations
present in WZhet, as contrasted with standard BamHI Z [20].
By placing site-specific mutations in BZLF1 and then introducing the plasmids into
cells with latent EBV it was shown that the protein encoded by BZLF1 was responsible
for disrupting latency. Those mutations which impaired the ability of the reading
frame to make protein also abolished the capacity of the plasmid to disrupt latency.
Since the responsible protein was encoded within BamHI Z, we called it ZEBRA (Z
EB Replication Activator).
Regulation ofZEBRA Differs in HR-I Cells With and Without het DNA (Fig. 2)
Recent experiments by Taylor have shown that the presence of het DNA affects
control of ZEBRA expression. In cells lacking het DNA (such as clone 16), neither
BZLF1 mRNA nor ZEBRA protein is made spontaneously. When clone 16 cells are
treated with chemical inducers, such as sodium butyrate, however, ZEBRA tran-
scription is stimulated and ZEBRA polypeptide is made [22].
By contrast, cells containing het DNA (such as clone 5) synthesize BZLF1 mRNA
and ZEBRA protein spontaneously. These results suggest that regulation of tran-
scription of BZLF1 differs in the standard and het genome and that this regulation is
the pivotal event in the switch between latency and replication.
Genome Rearrangements in het DNA Activate ZEBRA (Fig. 3)
Cliona Rooney explored those regions of the palindromic het DNA which are
responsible for activating expression of the BZLFI gene [23]. Her experimental
approach was to construct various plasmids containing BZLFI and to introduce them
using gene transfer techniques into cultured EBV genome-negative Burkitt lymphoma
cells. The expression of ZEBRA was monitored with a specific antiserum to the
protein. If the standard BamHl Z fragment was used, without the addition of a
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FIG. 2. Differences in the regulation of BZLF1 in HR-I cell clones with or without
het DNA. Clone 16 cells express only latent products, represented by shaded
nuclei. A subpopulation ofclone 5 cells produce virus. BZLF1 expression was studied
in untreated cells or after induction with TPA or butyrate. mRNA was estimated by
Northern blotting and ZEBRA protein was detected on Western blots probed with
monospecific antiserum to BZLF1.
heterologous promoter, no ZEBRA could be identified. The entire EcoRI het 16
palindrome produced a high level of ZEBRA expression. A much weaker signal was
seen with the WZhet subfragment; ifmore ofthe rearranged upstream sequences were
included, such as in the plasmids "pWoozie" or "pDbl Woozie" (Fig. 3), the signal
increased, but not to the level seen with EcoRI het 16. This finding indicated that
sequences downstream of BZLF1 in EcoRI het 16 were important. In related ex-
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FIG. 3. Genome rearrangements in het DNA activate ZEBRA. EcoRI het 16
and various other plasmids were cloned in pACYC184. In the diagrams of the
plasmids, the bold lines indicate rearranged sequences from the large internal repeat
(BamHI W); the hatched lines indicate rearranged sequences from BamHI S; the
letters refer to restriction endonuclease recognition sites (B, BamHI; R, EcoRI; H,
Hind III). They were transfected into EBV genome negative Burkitt lymphoma cells
by the DEAE Dextran method. ZEBRA expression was scored after 48 hours by
probing Western blots with the monospecific antiserum to BZLF1.THE SWITCH BETWEEN EBV LATENCY AND REPLICATION
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FIG. 4. Regulation of BZLF1 expression differs in het DNA and standard
EBV DNA. In het DNA, there are novel sequences upstream and down-
stream of BZLFI due to intramolecular recombinations. The BZLF1 gene is
transcribed spontaneously, and the ZEBRA protein is made. het ZEBRA has five
point mutations (dots) in comparison to standard ZEBRA. In the standard
genome, BZLF1 transcription is repressed, but inducing stimuli release tran-
scription ofat least two mRNAs which contain BZLF1. The larger mRNA also
contains BRLF1 [12]. ZEBRA positively activates its own expression.
periments, the effect of progressive deletions of the rearranged upstream BamHI W
sequences was examined when pSV2neo WZhet was transfected into BL cells carrying
a latent EBV genome. A region ofabout 900 bp ofBamHI W sequences appears to be
important for ZEBRA expression and for disruption of latency. Thus the genome
rearrangements ofhet DNA have brought novel upstream and downstream sequences
next to the BZLF1 open reading frame. The exact functional role played by these
rearrangments is not yet clear. Experiments so far indicate that they do not provide
trans active products, but are likely to be cis active signals which affect BZFL1
transcription. It is likely that the downstream elements function as "enhancers."
A summary of models for the regulation of BZLF1 transcription is found in Fig. 4.
In het DNA, BZLF1 is constitutively transcribed, presumably as the result of new
positive cis active elements which are newly positioned upstream and downstream of
the gene; however, the intramolecular recombinations in het DNA have also truncated
the normal region upstream of BZLF1 to 541 bp. If this region in standard virus
contains negative regulatory elements, then they have been removed in the recombina-
tion event.
In the standard genome there is suppression ofBZLF1 transcription, presumably as
the result of repressors encoded by the cell or by the virus or as the result of a lack of
positive regulatory elements. Chemical inducers turn on BZLF1 transcription, perhaps
by activating transcription factors or by removing or inactivating repressors. The
control point(s) of regulation are not yet clear. They may be directly upstream of
BZLF1 or possibly upstream of BRLF1 which is a gene co-linear with BZLF1.
ZEBRA itself mav olav an autostimulatorv role in regulating its own transcription.
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TARGETS OF THE BZLF1 GENE
A central question is whether BZLF1 activates the expression ofmany EBV genes or
only one or a few. If the latter is the case, does it activate certain EBV genes directly,
e.g., by binding to DNA, or indirectly, perhaps by interaction with cellular
transcription factors?
Our general approach to this question has been to attempt to identify those genes
which are activated by ZEBRA. In our first such experiment BZLF1, carried on a
vector with a selectable marker (G418 resistance) was stably introduced into X50-7
cells with a latent genome, using the electroporation technique. Some clones of X50-7
cells which became resistant to the antibiotic also expressed early and late viral
replicative antigens [24]. One colony was subcloned; about half of the subclones
expressed early antigens, some expressed membrane antigens, and a few went on to
produce mature virus. One subclone yielded high titers of transforming virus. Three
clones which expressed replicative antigens also retained an integrated WZhet
fragment. From these experiments, we concluded that in some instances WZhet was
capable of driving the entire EBV replicative cycle to completion. A corollary of this
experiment was that in some cells both early and late viral genes are activated by
BZLF1 expression. Thus many viral genes are activated as the result of ZEBRA
expression.
There are several drawbacks to this set of experiments: (1) it was difficult to identify
and analyze the single copy of integrated WZhet DNA; (2) only one cell line, X50-7,
was studied; in this cell line ZEBRA activated a cascade leading to synthesis of virus;
(3) direct evidence that ZEBRA expression was correlated with the disruption of
latency was lacking.
In a recent series of experiments, we prepared BZLF1 plasmids which were carried
on vectors with the EBV plasmid origin (oriP) [25]. These were introduced stably into
three different cell lines using G418 selection. The extent of expression of EBV was
monitored by testing the BZLF1 transformants for virus and by assaying them with a
panel of monoclonal antibodies to early and late EBV gene products. The remarkable
finding from this series of experiments was that each cell line responded to a different
extent to the introduction of the BZLF1 gene (Fig. 5). X50-7 cells made early and late
products and released transforming virus, as they had in earlier experiments when
WZhet was introduced without oriP. Since the introduced BZLF1 gene was derived
from the het DNA, it was marked with the polymorphic protein marker. Therefore it
could be shown that cells which responded produced ZEBRA from the endogenous
genome as well as from the plasmid which was introduced. This finding indicated that
ZEBRA is autostimulatory. X50-7.17, a single cell subclone of the X50-7 line,
produced late viral antigens representing the viral envelope but never released any
infectious virus. By contrast Raji cells made only early antigens.
These experiments led to several conclusions. Early genes are the proximal targets of
BZLF1 action. The ZEBRA product does not directly influence late genes in Raji cells
and, by inference, probably not in X50-7 cells. Additional cell or viral factors must be
required beyond the point of ZEBRA action to drive the viral replicative cycle into
viral DNA synthesis, late gene expression, and virion production.
CELL BACKGROUND
It has been known for many years that the cell background plays a crucial role in the
regulation of EBV expression [26]. Host cell species and even age of the donor of the
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FIG. 5. Stable activation ofEBV early genes byoriP/BZLFl plasmids. A series
of cell lines which were resistant to G418 were derived after transfection with
pSV2neo/oriP/BZLFl plasmids. The resultant transformed cells were scored for
expression of EBV replicative functions with a panel of monoclonal antibodies and
were tested for release ofvirus which could immortalize lymphocytes. Only X50-7 cells
released virions. A clone of X50-7 cells made late antigens. Raji cells expressed only
early genes. The length ofthe arrows indicates extent ofprogression along thepathway
ofreplicative gene expression.
target cell play a role in the extent to which the virus switches from latency into
replication. This cell control is likely to act at the level of control of ZEBRA. For
example, the same virus strain, B95-8, has been used to infect three different sorts of
cells: EBV genome negative Burkitt lymphoma cells, human umbilical cord lympho-
cytes, and marmoset cells. These three cell types differ in their regulation ofEBV from
tightly latent (the Burkitt lymphoma cells) to inducible (the umbilical cord cells) to
productive (the marmoset cells). The controls correlate with ZEBRA expression,
which is either tightly restricted, inducible, or spontaneously active (Table 1). Thus the
cells' control on ZEBRA expression is likely to account for different levels of EBV
replication.
TABLE 1
Cell Controls on ZEBRA Expression by Standard EBV
Expression ofEndogenous ZEBRA
Inducible by
Behavior Cells/Virus Spontaneous TPA het(+) Virus
Tightly latent BL41/B95-8 - - -
Latent/Inducible X50-7/B95-8 - +/- +
Productive B95-8/B95-8 + + +
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FIG. 6. Proposed pathway for activa-
tion of latent EBV. Both sponta-
neous and chemically induced activa-
tion ofreplication are thought to induce
BZLFI transcription, but the mecha-
nism is unknown. The ZEBRA poly-
peptide activates EBV early gene
expression, perhaps by DNA binding
and transcriptional activation. Addi-
tional host cell and viral factors are
required for entry into viral DNA syn-
thesis, EBV late gene expression, and
virus maturation.
SUMMARY
It now seems likely that control of transcription of the BZLF1 gene mediates the
switch from latency to replication which occurs during spontaneous activation (mar-
moset cells), chemical-induced activation, or activation by HR-I virus with het DNA
(Fig. 6). The ZEBRA polypeptide then activates a number of EBV early genes by a
mechanism which is unknown but presumably involves DNA binding. Additional viral
and cellular gene products are needed to permit the virus to enter lytic viral DNA
synthesis and to produce late genes and viral particles. It is likely that host cell
permissivity factors arecrucial in theselater steps. Thesepermissivity factors may well
be closely related to cell differentiation, since it is known that EBV is latent in
lymphocytes but replicates in epithelial cells.
ACKNOWLEDGEMENT
Work in the author's laboratory was supported by grants from the NIH (CA12055, A122959, CA16038)
and the American Cancer Society (NP-6691). I am grateful for collaborations with many colleagues,
including Jill Countryman, Lyn Gradoville, Elizabeth Grogan, Lee Heston, Hal Jenson, David Katz, J.
Kolman, Michael Rabson, Cliona Rooney, Duane Shedd, and Naomi Taylor who worked with me on the
latency to replication switch.
REFERENCES
1. Rowe DT, Farrell PJ, Miller G: Novel nuclear antigens recognized by human sera in lymphocytes
latently infected by Epstein-Barr virus. Virology 156:153-162, 1987
2. Lerner MR, Andrews NC, Miller G, Steitz JA: Two small RNAs encoded by Epstein-Barr virus and
complexed with protein are precipitated byantibodies from patients with systemic lupus erythematosus.
Proc Natl Acad Sci USA 78:805-809, 1981THE SWITCH BETWEEN EBV LATENCY AND REPLICATION 213
3. Laux G, Perricaudet M, Farrell PJ: Epstein-Barr virus gene expressed in immortalised lymphocytes is
created by circularisation oftheviral genome. EMBO J 7:769-774, 1988
4. Fennewald S, Van Santen V, Kieff E: Nucleotide sequence of an mRNA transcribed in latent growth
transformed infection indicates that it may encode a membrane protein. J Virol 51:411-419, 1984
5. Hennessy K, Wang F, Bushman EW, KieffE: Definitive identification ofa member ofthe Epstein-Barr
virus nuclear protein 3 family. Proc Natl Acad Sci USA 83:5693-5697, 1986
6. Summers WP, Grogan EA, Shedd D, Robert M, Liu C-R, Miller G: Stable expression in mouse cells of
nuclearneoantigen aftertransfer ofa 3.4 megadalton cloned fragmentofEpstein-Barr virus DNA. Proc
Natl Acad Sci USA 79:5688-5692, 1982
7. Miller G, Robinson J, Heston L, Lipman M: Differences between laboratory strains of Epstein-Barr
virus based on immortalization, abortive infection and interference. Proc Natl Acad Sci USA
71:4006-4010, 1974
8. Rabson M, Gradoville L, Heston L, Miller G: Non-immortalizing P3J-HR-1 Epstein-Barr virus: A
deletion mutant ofits transforming parent, Jijoye. J Virol 44:834-844, 1982
9. Bornkamm GW, Hudewentz J, Freese UK, Zimber U: Deletion of the nontransforming Epstein-Barr
virus strain P3HR-1 causes fusion of the large internal repeat to the DSL region. J Virol 43:952-968,
1982
10. Wang F, Petti L, Braun D, Seung S, Kieff E: A bicistronic Epstein-Barr virus mRNA encodes two
nuclear proteins in latently infected, growth-transformed lymphocytes. J Virol 61:945-954, 1987
11. Rooney C, Howe JG, Speck SH, Miller G: Influences of Burkitt's lymphoma and primary B cells on
latent gene expression by the nonimmortalizing strain of Epstein-Barr virus. J Virol 63:1531-1539,
1989
12. Henle W, Henle G, Zajac BA, Pearson G, Waubke R, Scriba M: Differential reactivity of human
serums with early antigens induced by Epstein-Barr virus. Science 169:188-190, 1970
13. Heston L, Rabson M, Brown N, Miller G: New Epstein-Barr virus variants from cellular subclones of
P3J-HR-1 Burkitt lymphoma. Nature (London) 295:160-163, 1982
14. Rabson M, Heston L, Miller G: Identification ofa rare Epstein-Barr virus variant that enhances early
antigen expression in Raji cells. Proc Natl Acad Sci USA 80:2762-2766, 1983
15. Miller G, Rabson M, Heston L: Epstein-Barr virus with heterogeneous DNA disrupts latency. J Virol
50:174-182, 1984
16. Miller G, Heston L, Countryman J: P3HR-1 Epstein-Barr virus with heterogeneous DNA is an
independent replicon maintained by cell-to-cell spread. J Virol 54:45-52, 1985
17. Jenson HB, Rabson MS, Miller G: Palindromic structure and polypeptide expression of 36 kilobase
pairs ofheterogeneous Epstein-Barr virus (P3HR-1) DNA. J Virol 58:475-486, 1986
18. Jenson HB, Farrell PJ, Miller G: Sequences ofthe Epstein-Barr virus (EBV) large internal repeat form
the center of a 16-kilobase-pair palindrome of EBV (P3HR-1) heterogeneous DNA. J Virol 61:1495-
1506, 1987
19. Countryman J, Miller G: Activation ofexpression oflatent Epstein-Barr herpesvirus after genetransfer
with a small cloned subfragment ofheterogeneous viral DNA. Proc Natl Acad Sci USA 82:4085-4089,
1985
20. Jenson HB, Miller G: Polymorphisms of the region of the Epstein-Barr virus genome which disrupts
latency. Virology 165:549-564, 1988
21. Countryman J, Jenson H, Seibl R, Wolf H, Miller G: Polymorphic proteins encoded within BZLF1 of
defective and standard Epstein-Barr viruses disrupt latency. J Virol 61:3672-3679, 1987
22. Taylor N, Countryman J, Rooney C, Katz D, Miller G: Expression of the BZLF1 latency disrupting
gene differs in standard and defective Epstein-Barr viruses. J Virol 63:1721-1728, 1989
23. Rooney C, Taylor N, Countryman J, Jenson H, Kolman J, Miller G: Genome rearrangements activate
the Epstein-Barr virus gene whose product disrupts latency. Proc Natl Acad Sci USA 85:9801-9805,
1988
24. Grogan E, Jenson H, Countryman J, Heston L, Gradoville L, Miller G: Transfection of a rearranged
viral DNA fragment, WZhet, stably converts latent Epstein-Barr virus infection to productive infection
in lymphoid cells. Proc Natl Acad Sci USA 84:1332-1336, 1987
25. Yates J, Warren N, Reisman D, Sugden B: A cis-acting element from the Epstein-Barr viral genome
that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci
USA 81:3806-3810, 1984
26. Miller G, Lipman M: Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.
Proc Natl Acad Sci USA 70:190-194, 1973